Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    "Factor VII deficiency"
Show Display Options
Rank Status Study
1 Completed Treatment of Inherited Factor VII Deficiency
Condition: Factor VII Deficiency
Interventions: Drug: plasma derived Factor VII;   Drug: recombinant FVIIa;   Drug: Fresh Frozen Plasma;   Drug: Activated Prothrombin Complex Concentrates;   Drug: Virus Inactivated plasma
2 Active, not recruiting Study of the Pharmacokinetics and Safety of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) in Patients With Congenital Factor VII Deficiency
Condition: Congenital Coagulation Factor VII Deficiency
Interventions: Biological: Eptacog alfa (activated) or pdFVII;   Biological: CSL689
3 Completed Treatment of Congenital Factor VII Deficiency
Conditions: Congenital Bleeding Disorder;   Congenital FVII Deficiency
Interventions: Drug: activated recombinant human factor VII;   Drug: Fresh frozen plasma (Source unspecified);   Drug: Plasma-derived FVII (LFB);   Drug: Prothrombin Complex conc. (PCC);   Drug: Plasma-derived FVII conc. (pdFVII Baxter);   Drug: Plasma-derived FVII conc. (pdFVII PFL)

Indicates status has not been verified in more than two years